| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/09/2006 | CN1268640C Glucagon-like peptide-2 analogs |
| 08/09/2006 | CN1268637C I (chlamydia) protein, gene sequence and uses thereof |
| 08/09/2006 | CN1268636C Dolastatin 15 derivatives |
| 08/09/2006 | CN1268618C 1,5-benzothiazepines compounds and its use as antilipemic agent |
| 08/09/2006 | CN1268400C Synechia inhibitory material |
| 08/09/2006 | CN1268394C Binding domain-immunoglobulin fusion proteins |
| 08/09/2006 | CN1268391C Use of GLP-1 analogs and derivatives administered peripherally in regulation of obesity |
| 08/09/2006 | CN1268390C Applicaton of alpha interferon in external used medicine for treating eczema |
| 08/09/2006 | CN1268345C Method of treating hepatitis delta viral infection |
| 08/09/2006 | CN1268338C Oral administration of 6-hydroxy-oxymorphone for use as antalgesic |
| 08/09/2006 | CN1268234C Method and compositions for increasing anaerobic working capacity in tissues |
| 08/08/2006 | USRE39229 libraries of DNA sequences encoding zinc finger binding motifs for display on a particle; designing zinc finger binding polypeptides for binding to a target sequence |
| 08/08/2006 | US7087743 Bleaching; skin disorders; genetic engineered nucleic acid; topical applying |
| 08/08/2006 | US7087741 Nucleic acids encoding novel proteins in enteroaggregative escherichia coli (EAEC) |
| 08/08/2006 | US7087729 Peptide conjugates for the stabilization of membrane proteins and interactions with biological membranes |
| 08/08/2006 | US7087728 Crystal proteins which display stability to harsh environmental conditions; pronase resistance |
| 08/08/2006 | US7087725 Antibodies specifically reactive with a tumor necrosis factor related ligand |
| 08/08/2006 | US7087724 Carrier molecules |
| 08/08/2006 | US7087723 Stable in the absence of albumin or other proteins |
| 08/08/2006 | US7087721 Compositions, kits and treating methods for alteration cell-cell adhesion, transport, or permeation properties of tissues |
| 08/08/2006 | US7087719 Isolation of crystalline colloid for treatment of severe edema, pancreatitis, adult respiratory distress syndrome (ARDS), liver disorders and burn injuries |
| 08/08/2006 | US7087718 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 08/08/2006 | US7087717 Comprises nucleotide sequences coding nuclear hormone receptor co-activator for diagnosis and treatment of liver disorders |
| 08/08/2006 | US7087715 Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses |
| 08/08/2006 | US7087714 Mu-Opiod receptor splice variant polypeptides |
| 08/08/2006 | US7087713 Polypeptides that contain at least one immunogenic portion of one or more Mycobacterium proteins and DNA encoding said proteins |
| 08/08/2006 | US7087712 Peptide for triggering an immune reaction against tumor cells |
| 08/08/2006 | US7087600 Anticancer agents; side effect reduction |
| 08/08/2006 | US7087586 Oligonucleotide compositions and their use to induce differentiation of cells |
| 08/08/2006 | US7087585 Tripeptide of FcγRIIA |
| 08/08/2006 | US7087584 Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative disease |
| 08/08/2006 | US7087581 Regeneration of sensitive cells with cell proliferative agents; cyclin-dependent kinase inhibitor; administering antibody |
| 08/08/2006 | US7087580 Nuclease resistant; for inhibiting neovascularization; gene expression; genetic engineering; antitumor agents |
| 08/08/2006 | US7087578 Administering activated protein c; controlling blood coagulation |
| 08/08/2006 | US7087577 Method of promoting natural bypass |
| 08/08/2006 | US7087576 Dipeptide phenyl ethers |
| 08/08/2006 | US7087575 Treating the effect of nicotine |
| 08/08/2006 | US7087574 Brain associated inhibitor of tissue-type plasminogen activator |
| 08/08/2006 | US7087573 Genetic engineered protein |
| 08/08/2006 | US7087432 Fad4, Fad5, Fad5-2 and Fad6, novel fatty acid desaturase family members and uses thereof |
| 08/08/2006 | US7087427 Mammalian alpha-kinase proteins, nucleic acids and diagnostic and therapeutic uses thereof |
| 08/08/2006 | US7087411 Nucleic acids; fusion protein; binding to endothelial growth factor |
| 08/08/2006 | US7087407 Beta-defensins |
| 08/08/2006 | US7087399 Purification; analyzing; drug screening; Alzheimer's diseases; central nervous system disorders |
| 08/08/2006 | US7087394 Gene expression of polypeptides; induce glucose stimulation insulin production |
| 08/08/2006 | US7087377 Method and kit for detection of tat protein with anti-tat oyi antibodies |
| 08/08/2006 | US7087372 Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies |
| 08/08/2006 | US7087248 Pharmaceutical component based on human parathyroid hormone and a pharmaceutical composition for intranasal administration comprising the component |
| 08/08/2006 | US7087247 Polyesters, method for producing same, and depot medicaments produced from these polyesters |
| 08/08/2006 | US7087246 Controlled release preparation of insulin contains microparticles obtained by microencapsulation of uniform microcystals of insulin using biodegradable polymeric materials. Since the denaturation of insulin that may occur |
| 08/08/2006 | US7087245 Intracelluloar adhesion molecules |
| 08/08/2006 | US7087244 Thermogelling oligopeptide polymers |
| 08/08/2006 | US7087237 Ocular solutions |
| 08/08/2006 | US7087231 In situ diagnosis of malaria |
| 08/08/2006 | US7087230 Proteins in enteroaggregative escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/08/2006 | US7087229 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 08/08/2006 | US7087228 prevention or prophylaxis of dental caries and endocarditis comprising Streptococcus mutans Competence Stimulating Peptide and sucrose; minimizes the attachment of S. mutans to teeth, and consequently minimize the negative consequences |
| 08/08/2006 | US7087225 Nucleotide sequences coding polypeptide for use in treatment, diagnosis and prevention of bone disorders |
| 08/08/2006 | US7087224 Method of treating anemia by administering IL-1ra |
| 08/08/2006 | US7087215 Methods of administering and enhancing absorption of pharmaceutical agents |
| 08/08/2006 | CA2110899C Orally administrable therapeutic proteins and method of making |
| 08/08/2006 | CA2097063C Tissue sealant and growth factor containing compositions that promote accelerated wound healing |
| 08/08/2006 | CA2071875C Recombinant human factor viii derivative |
| 08/03/2006 | WO2006081546A2 Inhibitor nucleic acids |
| 08/03/2006 | WO2006081522A2 Modulation of nmda receptor currents via orexin receptor and/or crf receptor |
| 08/03/2006 | WO2006081494A2 Induction of tumor cell senescence by retinoid receptor agonists and antagonists |
| 08/03/2006 | WO2006081425A1 Phosphorylation and regulation of akt/pkb by the rictor-mtor complex |
| 08/03/2006 | WO2006081418A2 Ephb receptor-binding peptides |
| 08/03/2006 | WO2006081320A2 Pharmaceutical formulation |
| 08/03/2006 | WO2006081311A2 Compositions and methods for the intracellular disruption of vegf and vegfr-2 by intraceptors |
| 08/03/2006 | WO2006081279A2 Control of drug release by transient modification of local microenvironments |
| 08/03/2006 | WO2006081014A2 Cytochrome p450 enzyme complexes and methods of treatment using the same |
| 08/03/2006 | WO2006080952A2 Improved modalities for the treatment of degenerative diseases of the retina |
| 08/03/2006 | WO2006080951A2 Targeted and high density drug loaded polymeric materials |
| 08/03/2006 | WO2006080941A1 Methods and compositions for reducing ischemia-derived microvascular damage |
| 08/03/2006 | WO2006080920A1 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof |
| 08/03/2006 | WO2006080903A2 High concentration self-microemulsifying coenzyme q10 preparations for nutritional use |
| 08/03/2006 | WO2006080756A1 Method and pharmaceutical composition for preventing or treating diseases associated with inflammation |
| 08/03/2006 | WO2006080522A1 Food or drug comprising lactic acid bacterium containing mineral |
| 08/03/2006 | WO2006080508A1 Transdermal absorption preparation, sheet holding transdermal absorption preparation and transdermal absorption preparation holder |
| 08/03/2006 | WO2006080483A1 Novel dendritic cell membrane molecule and dna encoding the same |
| 08/03/2006 | WO2006080451A1 Process for producing coated fine particle |
| 08/03/2006 | WO2006080424A1 Low allergen milk obtained using electrical energy |
| 08/03/2006 | WO2006080340A1 Concomitant use of hepatitis c virus-origin peptide with interferon |
| 08/03/2006 | WO2006080171A1 Immunopotentiating agent |
| 08/03/2006 | WO2006080142A1 Hla-binding peptides, dna fragments encoding the same and recombinant vectors |
| 08/03/2006 | WO2006080017A2 Biologically active silver-coated proteins |
| 08/03/2006 | WO2006079811A1 Reducing drug dependence or addiction |
| 08/03/2006 | WO2006079796A1 Treatment for mucositis |
| 08/03/2006 | WO2006079722A2 Compositions for freeze-drying proteins |
| 08/03/2006 | WO2006079288A1 Use of human lysozyme for preparing cosmetics against acne |
| 08/03/2006 | WO2006079217A1 Treatment of degenerative diseases with the x-linked inhibitor of apoptosis |
| 08/03/2006 | WO2006079176A1 Molecules and chimeric molecules thereof |
| 08/03/2006 | WO2006079169A1 Parameter selected gm-csf, il-3, il-4, il-5 and chimeras thereof for therapeutic and diagnostic purposes |
| 08/03/2006 | WO2006063470B1 Metabolites of cyclosporin analogs |
| 08/03/2006 | WO2006058620A3 Method for producing carboxy-terminal amidified peptides |
| 08/03/2006 | WO2006057997A3 Plasmin-inhibitory therapies |
| 08/03/2006 | WO2006054096A3 Soluble bifunctional proteins |
| 08/03/2006 | WO2006052926A3 Tweak as a therapeutic target for treating central nervous system diseases associated with cerebral edema and and cell death |
| 08/03/2006 | WO2006052840A3 Bone tropic peptides |